Delos Reyes, Lucan Robin D.

HRN: 14-43-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/11/2022
04/21/2022
ORAL
7.5 Ml
TID
Amoebiasis
05/18/2022
CEFUROXIME 750MG (VIAL)
05/18/2022
05/24/2022
IVT
400mg
Q8
UTI
Waiting Final Action 
05/26/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/26/2022
06/01/2022
PO
4ml
Tid
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: